# Angiodynamics Inc (NASDAQ: ANGO), Marlborough, MA – FDA Inspections

Source: https://www.keypedia.com/companies/angiodynamics-inc/2ed1a455-cff3-42f8-976b-7067b69f68aa

> Inspection records and compliance data for Angiodynamics Inc in Marlborough, Massachusetts. 8 FDA inspections on record (1 OAI), last inspected September 26, 2018. Publicly traded as NASDAQ: ANGO.

---

## Details

- Name: Angiodynamics Inc
- FEI Number: 1000523114
- Address Line 1: 26 Forest St
- City: Marlborough
- State: Massachusetts
- Zip Code: 01752
- Country Name: United States
- Address: 26 Forest St, Marlborough, Massachusetts 01752, United States
- Country: United States

## Stock

- Stock ticker: ANGO
- Exchange: NASDAQ
- Share price: $11.80
- Market cap: $496.2M
- Price as of: November 6, 2026

## Related Documents

- FDA Inspection 1122886 - Angiodynamics Inc - 2018-09-26 — source: FDA, date: September 26, 2018
- [FDA Inspection 942381 - Angiodynamics Inc - 2015-08-24](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/a6944a2c-89f1-4043-93b2-61ef3eadc427) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2015
- [FDA Inspection 942383 - Angiodynamics Inc - 2015-08-24](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/3e0676c6-55ca-4e8b-a06a-412ff0339f27) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2015
- [FDA Inspection 882250 - Angiodynamics Inc - 2014-05-28](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/10d368b6-c525-4da7-b9f5-8ab4bb830c1c) — classification: Official Action Indicated (OAI), source: FDA, date: May 28, 2014
- [FDA Inspection 764802 - Angiodynamics Inc - 2012-02-13](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/363e6b69-f616-4c19-956a-b9b30e050d62) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2012
- FDA Inspection 745689 - Angiodynamics Inc - 2011-09-16 — classification: No Action Indicated (NAI), source: FDA, date: September 16, 2011
- FDA Inspection 718408 - Angiodynamics Inc - 2011-04-06 — classification: No Action Indicated (NAI), source: FDA, date: April 6, 2011
- FDA Inspection 718408 - Angiodynamics Inc - 2011-04-06 — classification: No Action Indicated (NAI), source: FDA, date: April 6, 2011
- FDA Inspection 556381 - Angiodynamics Inc - 2009-01-09 — classification: No Action Indicated (NAI), source: FDA, date: January 9, 2009

## Related Companies

- [Gregory G. Allen, Jr., D.O.](https://www.keypedia.com/companies/gregory-g-allen-jr-do/4d6ad775-cb79-4a87-b905-4c43ddafaec8)
- [Ruth E. Tedaldi, MD](https://www.keypedia.com/companies/ruth-e-tedaldi-md/8af89027-a9ea-40a2-a311-4e4ddc91f165)
- [SPINEVISION INC](https://www.keypedia.com/companies/spinevision-inc/78d918da-c8cc-44e3-8bbe-1e61056cbf78)
- [Good Fit Technologies, LLC](https://www.keypedia.com/companies/good-fit-technologies-llc/a4273701-323a-4b73-ba06-02b1c1de4d2a)
- [Cataki International Inc.](https://www.keypedia.com/companies/cataki-international-inc/68f58c5d-872a-495b-86cf-4aed55d09c25)
- [CardioRenal Systems, Inc.](https://www.keypedia.com/companies/cardiorenal-systems-inc/21f3e26a-1374-4d7a-bbbd-1494e3e37f48)
- [Pear Therapeutics, Inc.](https://www.keypedia.com/companies/pear-therapeutics-inc/e35226e1-8b8e-4c8d-b3b2-41e427461da3)
- [Vickie Driver, DPM](https://www.keypedia.com/companies/vickie-driver-dpm/4f3df19c-3991-4ef6-b374-ef58d7ffc65e)
- [Hettich Instruments Lp](https://www.keypedia.com/companies/hettich-instruments-lp/f2eed2e1-7d83-498e-9cdf-6be49d3f4f76)
- [Solace Therapeutics, Inc.](https://www.keypedia.com/companies/solace-therapeutics-inc/1e6481f4-b72a-4e89-9492-beaa1332b281)